ArticleThe oncologist2025

Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.

Flavia Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.